Regeneron Pharmaceuticals, Inc.
Methods of assessing antibody-drug conjugates
Last updated:
Abstract:
The present disclosure provides methods of assessing DAR of ADC products that provide advantages over known methods. Specifically, methods of the disclosure can be used in high-throughput applications and/or without having to dilute ADC samples during the assessment.
Status:
Grant
Type:
Utility
Filling date:
5 Sep 2018
Issue date:
13 Apr 2021